The Amacore Group Stock Fundamentals
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Amacore's long-term financial health and intrinsic value.
Amacore |
The Amacore Group Company Shares Outstanding Analysis
Amacore's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Amacore Shares Outstanding | 1.05 B |
Most of Amacore's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The Amacore Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, The Amacore Group has 1.05 B of shares currently outstending. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The shares outstanding for all United States stocks is 83.23% lower than that of the firm.
Amacore Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amacore's current stock value. Our valuation model uses many indicators to compare Amacore value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amacore competition to find correlations between indicators driving Amacore's intrinsic value. More Info.The Amacore Group is number one stock in return on asset category among its peers. It also is number one stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amacore by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amacore's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Amacore Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amacore's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Amacore could also be used in its relative valuation, which is a method of valuing Amacore by comparing valuation metrics of similar companies.Amacore is currently under evaluation in shares outstanding category among its peers.
Amacore Fundamentals
| Return On Asset | -0.64 | |||
| Profit Margin | (0.73) % | |||
| Operating Margin | (0.56) % | |||
| Current Valuation | 1.05 M | |||
| Shares Outstanding | 1.05 B | |||
| Price To Earning | (0.03) X | |||
| Price To Sales | 0.0004 X | |||
| Revenue | 28.83 M | |||
| Gross Profit | 9.4 M | |||
| EBITDA | (12.98 M) | |||
| Net Income | (10.74 M) | |||
| Cash And Equivalents | 2.37 M | |||
| Debt To Equity | (2.22) % | |||
| Current Ratio | 0.54 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (15.23 M) | |||
| Earnings Per Share | (0.03) X | |||
| Number Of Employees | 89 | |||
| Beta | 2.64 | |||
| Market Capitalization | 10.48 K | |||
| Total Asset | 12.05 M | |||
| Retained Earnings | (165.62 M) | |||
| Working Capital | 866 K | |||
| Current Asset | 10.09 M | |||
| Current Liabilities | 9.22 M | |||
| Z Score | -19.5 | |||
| Net Asset | 12.05 M |
About Amacore Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze The Amacore Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amacore using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The Amacore Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.The Amacore Group, Inc. provides and markets healthcare-related membership products for individuals and families. The company was founded in 1993 and is based in Maitland, Florida. AMACORE GROUP operates under Medical Care Facilities classification in the United States and is traded on PNK Exchange. It employs 89 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Amacore Pink Sheet
Amacore financial ratios help investors to determine whether Amacore Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amacore with respect to the benefits of owning Amacore security.